ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting.

about

Predictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of Options ERCC1 and the Prognosis for Patients With Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy.

P2860

Q26738655-CB2F3958-CAE3-4382-923E-70D30C7DE6FA Q41202321-90E90717-EB3B-4B02-8F9A-4D67BA89BBFD

P2860

ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting.

Item

http://www.wikidata.org/entity/Q35833376

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting.

@ast

ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting.

@en

type

Item

label

ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting.

@ast

ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting.

@en

prefLabel

ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting.

@ast

ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting.

@en

P1476

ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting.

@en

P2093

Bo Mi Kim

http://www.w3.org/2001/XMLSchema#string

Chee Young Kim

http://www.w3.org/2001/XMLSchema#string

Ji Hyun Kim

http://www.w3.org/2001/XMLSchema#string

Jin Won Hwang

http://www.w3.org/2001/XMLSchema#string

Ki Beom Bae

http://www.w3.org/2001/XMLSchema#string

Kwan Hee Hong

http://www.w3.org/2001/XMLSchema#string

Kwang Hee Kim

http://www.w3.org/2001/XMLSchema#string

Mi Seon Kang

http://www.w3.org/2001/XMLSchema#string

Min Kyung Oh

http://www.w3.org/2001/XMLSchema#string

Min Sung An

http://www.w3.org/2001/XMLSchema#string

P2860

A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer.

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer.

Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.

Association between ERCC1 and TS mRNA levels and disease free survival in colorectal cancer patients receiving oxaliplatin and fluorouracil (5-FU) adjuvant chemotherapy

Polymorphisms in DNA repair genes and associations with cancer risk.

Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy.

Persistent high postoperative carcinoembryonic antigen in colorectal cancer patients--is it important?

Cellular and molecular pharmacology of oxaliplatin.

Molecular mechanisms of resistance and toxicity associated with platinating agents.

Prediction of cancer incidence and mortality in Korea, 2012

P304

92-97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3393/AC.2015.31.3.92

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279966561

http://www.w3.org/2001/XMLSchema#string

P698

26161376

http://www.w3.org/2001/XMLSchema#string

P932

4496459

http://www.w3.org/2001/XMLSchema#string

ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting.

about

P2860

P2860

ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932